MultidisciplinarySurgicalPrecisionandHIPECTherapyGives24-Year-OldaNewLeaseonLife

Hyderabad, April 22, 2025 – Malla Reddy Narayana Hospital, Hyderabad is a premier cancer care centre in Telangana, announcedaremarkablemedicalachievement:the successful treatment of a rare case of Primary Peritoneal Ewing’s Sarcoma using an advanced procedure involving Cytoreductive Surgery (CRS) followed by Hypothermic Intraperitoneal Chemotherapy (HIPEC).

 

This rare and complex case involved 24-year-old Mr. Kumar, who had previously undergone two lines of chemotherapy at other institute came to the Cancer Center of Malla Reddy Narayana Hospital, he was diagnosed with Primary Peritoneal Ewing’sSarcoma,anexceptionallyrareandaggressivemalignancythattypicallydoesnotoccur in the peritoneum. The diagnosis and subsequent treatment required a high level of expertise and precision, provided by a multidisciplinary oncology team led by Dr. Harish Dara, Senior Consultant – Surgical Oncology.

 

The surgical team undertook a challenging 16-hour procedure, which included complete tumor debulkingfollowedbythedirectinfusionofheatedchemotherapyintotheabdominalcavity—a technique known as HIPEC. This innovative method is designed to eradicate any residual microscopic cancer cells, enhance chemotherapy absorption, and minimize damage to healthy tissues.

 

HIPEC, now available at Malla Reddy Narayana Cancer Hospital, represents a significant advancement in the treatment of abdominal cancers such as ovarian, colorectal, gastric cancers, pseudomyxoma peritonei, mesothelioma, and certain rare sarcomas. Unlike conventionalchemotherapy,HIPECisdeliveredintra-operativelyatelevatedtemperatures, significantly improving clinical outcomes.

 

Thissuccessfulcaseexemplifiesthehospital’sabilitytomanagerareandcomplexoncological conditions through advanced medical technology, surgical expertise, and a patient-centric approach.

 

Quotesand Commentary

Dr.HarishDara,SeniorConsultant,SurgicalOncology,commented:

“Thiscaserepresentsthebestofsurgicalinnovationandteamcollaboration.Whencombined with complete cytoreduction, HIPEC can offer patients a real chance at long-term survival in

situationswheretraditionaltreatmentoptionsfallshort.”

 

Dr.G.NarendraPrakash,SeniorAnaesthetist, shared:

“The success of this high-risk surgery required seamless coordination across multiple departments.Intraoperativestabilitywascritical,andweensuredcontinuousmonitoringand management throughout the extended duration of the procedure.”

 

Dr.Ch.BhadraReddy,Chairman,MallaReddyVishwavidyapeeth,stated:

“This extraordinary case reflects our ongoing mission to bring advanced and accessible cancer caretotheregion.Wecontinuetoinvestininfrastructure,technology,andexpertisethatallow us to manage even the rarest and most challenging cases with confidence and care.”

 

Dr.Ch.PreethiReddy,Vice-Chairman,MallaReddyVishwavidyapeeth,stated:

“TreatingPrimaryPeritonealEwing’sSarcomawithadvancedHIPECisextremelyrare—both globally and in India—due to the rarity of the disease and the specialized nature of the treatment. It demands highly skilled surgeons, specialized infrastructure, and a dedicated multidisciplinaryteam.Malla ReddyNarayanaCancer Hospital standsamongIndia’sleading

advancedcancercentres.WeareproudtoannouncethissuccessandIsincerelyappreciatethe commitment and excellence of our team of doctors.”

 

AboutMallaReddyNarayanaCancerHospital

Located in Suraram, Hyderabad, Malla Reddy Narayana Cancer Hospital is a state-of-the-art oncology centre offering comprehensive cancer care. Through advanced diagnostics, expert multidisciplinaryteams,andcutting-edgetreatmentssuchasHIPEC,thehospitalremainsatthe forefront of personalized, precision-driven cancer therapy.

 

Formoreinformation,pleasecontact:

•MallaReddyNarayanaCancerHospital,Suraram, Hyderabad

•Website:www.mallareddynarayana.com

•Toll-Free:8790387903